NCT06112392View on ClinicalTrials.gov

Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

NARecruitingINTERVENTIONAL
Enrollment

38

Participants

Timeline

Start Date

July 28, 2023

Primary Completion Date

June 30, 2024

Study Completion Date

June 30, 2024

Conditions
Stellate GanglionParkinson Disease
Interventions
DIAGNOSTIC_TEST

Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）

Treatment （Stellate ganglion block；Oral standard anti-Parkinson's drugs）

DIAGNOSTIC_TEST

Treatment （Oral standard anti-Parkinson's drugs）

Treatment （Oral standard anti-Parkinson's drugs）

Trial Locations (1)

510000

RECRUITING

Zhujiang Hospiatal, Guangzhou

All Listed Sponsors
lead

Zhujiang Hospital

OTHER